Quantcast

Latest Percutaneous coronary intervention Stories

2014-05-29 08:29:09

BASKING RIDGE, N.J., May 29, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the Phase 3 clinical development of Revolixys(TM) Kit (previously known as REG1), its first-in-class, actively controllable antithrombotic drug system, today announced that it will present at the Jefferies 2014 Global Healthcare Conference at 10 a.m. EDT on June 5, 2014, in New York City. A live audio webcast of the presentation will be available under the...

2014-05-28 23:12:04

Corindus Vascular Robotics will present benefits of its CorPath System during May 29 symposium, “Robotic Precision: A Tool to Standardize Today’s Cath Lab,” at SCAI 2014, May 28 –31 Waltham, MA (PRWEB) May 28, 2014 Corindus Vascular Robotics, the leader in precision vascular robotics, will showcase its CorPath System at the upcoming Society for Cardiovascular Angiography and Interventions (SCAI) 2014 annual scientific session, May 28 –31 in Las Vegas, NV. CorPath is the first...

2014-05-26 12:23:12

DUBLIN, May 26, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wkbfxj/coronary_stents) has announced the addition of the "Global Coronary Stents (Bare Metal Stents, Drug Eluting Stents and Bio-absorbable Stents) Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 A coronary stent is a tubular structured device made of a thin mesh of wire, which may also be coated with a polymer containing a drug, or...

2014-05-23 08:23:56

-- Sustained Safety Profile -- DURHAM, N.C., May 23, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced that long-term clinical outcomes from its DESSOLVE I and II clinical trials were presented at the EuroPCR conference in Paris, France this week. Presentations by principal investigator William Wijns, M.D., Ph.D. of the Cardiovascular Center in Aalst, Belgium, highlighted results of long-term clinical follow-up of the MiStent Sirolimus Eluting Absorbable Polymer Coronary...

2014-05-21 12:08:36

EuroPCR Optimizing treatment strategies is dependent on resources and geography A Great Debate at EuroPCR 2014 saw experts discussing the role of the two most valuable strategies to save the lives of ST-segment Elevation Myocardial Infarction (STEMI) patients: primary percutaneous coronary intervention (PCI) and thrombolysis. Both these are effective treatments that actively save lives, and when there is no option for primary percutaneous coronary intervention, thrombolysis is the...

2014-05-20 23:15:46

Accreditation for Cardiovascular Excellence (ACE) accredits academic medical center renowned as the birthplace of percutaneous coronary intervention (PCI). Washington, DC (PRWEB) May 20, 2014 The Accreditation for Cardiovascular Excellence (ACE) is proud to announce that Emory University Hospital and Emory University Hospital Midtown, Atlanta, GA, are the latest facilities recognized with provisional accreditation by ACE. Both academic hospitals successfully completed the ACE...

2014-05-15 16:28:10

-- Oral Presentations to Include New Long-Term Results from First-in-Human Study -- DURHAM, N.C., May 15, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced the updated three- and two-year clinical outcomes from its DESSOLVE I and II clinical trials, respectively, will be presented at the EuroPCR conference to be held in Paris, France from May 20 - 23. Two oral presentations will be made by William Wijns, M.D., Ph.D., Cardiovascular Center, Aalst, Belgium: -- DESSOLVE II...

2014-05-14 08:30:11

Conference Call and Webcast, May 14, 2014, at 8:30 a.m. EDT BASKING RIDGE, N.J., May 14, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage, Phase 3 clinical development of the Revolixys(TM) Kit (previously known as REG1), its first-in-class, actively controllable antithrombotic drug system, today announced its first quarter 2014 corporate highlights and financial results. A conference call and webcast to discuss the results...

2014-05-09 08:25:47

BASKING RIDGE, N.J., May 9, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the Compensation Committee of Regado's Board of Directors granted an inducement award pursuant to NASDAQ Listing Rule 5635(c)(4) to R. Don Elsey in connection with his employment as Regado's Senior Vice President, Finance,...

2014-05-07 08:32:21

BASKING RIDGE, N.J., May 7, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that it will hold a conference call and live audio webcast on Wednesday, May 14, 2014, at 8:30 a.m. EDT to discuss its first quarter 2014 financial results and corporate highlights. Interested participants and investors may...


Latest Percutaneous coronary intervention Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »
Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related